210 related articles for article (PubMed ID: 11031079)
1. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
2. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.
Mandel RJ; Spratt SK; Snyder RO; Leff SE
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14083-8. PubMed ID: 9391156
[TBL] [Abstract][Full Text] [Related]
3. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.
Kirik D; Rosenblad C; Bjorklund A; Mandel RJ
J Neurosci; 2000 Jun; 20(12):4686-700. PubMed ID: 10844038
[TBL] [Abstract][Full Text] [Related]
4. Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration.
Palfi S; Leventhal L; Chu Y; Ma SY; Emborg M; Bakay R; Déglon N; Hantraye P; Aebischer P; Kordower JH
J Neurosci; 2002 Jun; 22(12):4942-54. PubMed ID: 12077191
[TBL] [Abstract][Full Text] [Related]
5. Effect of the sonic hedgehog receptor smoothened on the survival and function of dopaminergic neurons.
Zhou X; Pace J; Filichia E; Lv T; Davis B; Hoffer B; Selman W; Luo Y
Exp Neurol; 2016 Sep; 283(Pt A):235-45. PubMed ID: 27317298
[TBL] [Abstract][Full Text] [Related]
6. A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study.
Healy-Stoffel M; Ahmad SO; Stanford JA; Levant B
J Neurosci Methods; 2012 Sep; 210(2):187-94. PubMed ID: 22850559
[TBL] [Abstract][Full Text] [Related]
7. Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration.
Hurtado-Lorenzo A; Millan E; Gonzalez-Nicolini V; Suwelack D; Castro MG; Lowenstein PR
Mol Ther; 2004 Sep; 10(3):507-24. PubMed ID: 15336651
[TBL] [Abstract][Full Text] [Related]
8. Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
Mahato AK; Kopra J; Renko JM; Visnapuu T; Korhonen I; Pulkkinen N; Bespalov MM; Domanskyi A; Ronken E; Piepponen TP; Voutilainen MH; Tuominen RK; Karelson M; Sidorova YA; Saarma M
Mov Disord; 2020 Feb; 35(2):245-255. PubMed ID: 31840869
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery of mitochondria for treatment of Parkinson's Disease model rats lesioned with 6-hydroxydopamine.
Chang JC; Chao YC; Chang HS; Wu YL; Chang HJ; Lin YS; Cheng WL; Lin TT; Liu CS
Sci Rep; 2021 May; 11(1):10597. PubMed ID: 34011937
[TBL] [Abstract][Full Text] [Related]
10. STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease.
Smit RD; Ghosh B; Campion TJ; Stingel R; Lavell E; Hooper R; Fan X; Soboloff J; Smith GM
Brain Res; 2024 Feb; 1824():148691. PubMed ID: 38030102
[TBL] [Abstract][Full Text] [Related]
11. Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease.
Leikas JV; Kohtala S; Theilmann W; Jalkanen AJ; Forsberg MM; Rantamäki T
J Neurochem; 2017 Aug; 142(3):456-463. PubMed ID: 28488766
[TBL] [Abstract][Full Text] [Related]
12. Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat.
Oo TF; Ries V; Cho J; Kholodilov N; Burke RE
J Comp Neurol; 2005 Mar; 484(1):57-67. PubMed ID: 15717300
[TBL] [Abstract][Full Text] [Related]
13. Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration.
Cohen AD; Zigmond MJ; Smith AD
Brain Res; 2011 Jan; 1370():80-8. PubMed ID: 21062624
[TBL] [Abstract][Full Text] [Related]
14. Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age.
Torres EM; Monville C; Lowenstein PR; Castro MG; Dunnett SB
Brain Res Bull; 2005 Dec; 68(1-2):31-41. PubMed ID: 16325002
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation.
Gasparotto J; Ribeiro CT; Bortolin RC; Somensi N; Rabelo TK; Kunzler A; Souza NC; Pasquali MAB; Moreira JCF; Gelain DP
Sci Rep; 2017 Aug; 7(1):8795. PubMed ID: 28821831
[TBL] [Abstract][Full Text] [Related]
16. Exercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging Rats.
Arnold JC; Salvatore MF
ACS Chem Neurosci; 2016 Feb; 7(2):227-39. PubMed ID: 26599339
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease.
Choi DH; Kim JH; Kim SM; Kang K; Han DW; Lee J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117752
[TBL] [Abstract][Full Text] [Related]
18. Substantia nigra dopaminergic neurons and striatal interneurons are engaged in three parallel but interdependent postnatal neurotrophic circuits.
Ortega-de San Luis C; Sanchez-Garcia MA; Nieto-Gonzalez JL; García-Junco-Clemente P; Montero-Sanchez A; Fernandez-Chacon R; Pascual A
Aging Cell; 2018 Oct; 17(5):e12821. PubMed ID: 30058223
[TBL] [Abstract][Full Text] [Related]
19. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease.
Kim SN; Doo AR; Park JY; Bae H; Chae Y; Shim I; Lee H; Moon W; Lee H; Park HJ
PLoS One; 2011; 6(11):e27566. PubMed ID: 22132113
[TBL] [Abstract][Full Text] [Related]
20. Time-Dependent Memory and Gait Improvement by Intranasally-Administered Extracellular Vesicles in Parkinson's Disease Model Rats.
Narbute K; Pilipenko V; Pupure J; Klinovičs T; Auders J; Jonavičė U; Kriaučiūnaitė K; Pivoriūnas A; Kluša V
Cell Mol Neurobiol; 2021 Apr; 41(3):605-613. PubMed ID: 32410106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
